Cargando…
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments....
Autores principales: | Bannister, Margaret, Berlanga, Jenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014794/ https://www.ncbi.nlm.nih.gov/pubmed/27502496 http://dx.doi.org/10.1007/s13300-016-0188-5 |
Ejemplares similares
-
HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011) -
Cutoff Point of HbA1c for Diagnosis of Diabetes Mellitus in Chinese Individuals
por: Wang, Bing, et al.
Publicado: (2016) -
Trends in HbA(1c) thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients
por: Ambrož, Martina, et al.
Publicado: (2020) -
The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus
por: Wu, Kui, et al.
Publicado: (2018) -
“New Twist” in Diabetes Care for HbA(1c) Reporting: “It Takes Two to Tango”!
por: Cefalu, William T., et al.
Publicado: (2012)